Home/Pipeline/Imatinib Intermediate

Imatinib Intermediate

Oncology

CommercialActive

Key Facts

Indication

Oncology

Phase

Commercial

Status

Active

Company

AR Life Science

About AR Life Science

Indian API manufacturer delivering GMP‑certified small‑molecule intermediates for global pharma.

View full company profile

Therapeutic Areas

Cardiovascular Oncology Diabetes Urology Psychiatry Anti-coagulant

Other Oncology Drugs

Drug	Company	Phase	Status
mRNA Anticancer Vaccine	Sunshine Biopharma	Preclinical Research	Active
Biosimilar Bevacizumab	Organon (2)	Phase 3	Active
Biosimilar Pembrolizumab	Organon (2)	Phase 3	Active
BCL-2 Inhibitor Program	Vincerx Pharma	Preclinical	Research
Attenukine Oncology Candidate	Teva	Phase 1	Active
XEMA Tumor Marker ELISA Kit	XEMA Group	Commercial	Active
KEAP1 Activator Program	Vividion Therapeutics	Phase 1	Active
Bendamustine Intermediate	AR Life Science	Commercial	Active
Dasatinib Intermediate	AR Life Science	Commercial	Active
Personalized Medicine Assays (Patient-Derived Explants)	Aurita Bioscience	Research-Use Only	Active
CDK2-CyclinE1 & CDK2-CyclinA2 Assay	Aurora Biolabs	Commercial	Available
POLQ & eIF4E Assay	Aurora Biolabs	Commercial	Available